Intragastric Balloon Market Size

Global Intragastric Balloon Market By Administration (Endoscopy and Pill Form) By Type (Single, Dual and Triple) By Filling Material (Gas Filled and saline Filled) By End Use (Clinics, Hospitals and Ambulatory Surgical Centers) By Region, Industry Analysis and Forecast, 2020 - 2026

Global Intragastric Balloon Market By Administration (Endoscopy and Pill Form) By Type (Single, Dual and Triple) By Filling Material (Gas Filled and saline Filled) By End Use (Clinics, Hospitals and Ambulatory Surgical Centers) By Region, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : May-2020 | Number of Pages : 213 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the Intragastric Balloon Market

The Global Intragastric Balloon Market size is expected to reach $77.5 Million by 2026, rising at a market growth of 12.4% CAGR during the forecast period. Intragastric balloons are gastric balloons made of soft biocompatible silicone material which is usually filled with sterile saline solutions or gas. These are implanted into non-surgical endoscopic procedures inside the stomach. When inflated, an intragastric balloon will reduce the volume of the stomach which makes a person feel fuller faster and longer. It also helps to minimize food consumption.

Global Intragastric Balloon Market Size

Intragastric Balloon Market Size

This procedure is an alternative for overweight and obese individuals with an index of body mass (BMI) ranging from 30 to 70 who are not eligible for weight-loss operations. Permanent healthy diet and exercise changes are necessary to ensure the intragastric balloon procedure is a success. The main advantage of this technique is that it helps avoid the complications associated with surgical procedures. Nevertheless, few disadvantages are that not all patients tolerate it, and the possibility of nausea and vomiting. These balloons can also result in weight loss failure if a patient does not adhere to diet and exercise.

A growing trend found on the market is the approval for this medical device by regulatory bodies such as the FDA in the US and its associated treatment followed by the American Society for Metabolic and Bariatric Surgery's acceptance nod. These approvals will likely also be replicated in other countries which will be a positive factor for the Intragastric Balloons industry as their application becomes more standardized.

Intragastric Balloon Market Share

Intragastric Balloon Market Share

Intragastric balloons have been used progressively in the treatment of obesity and to induce weight loss. Numerous upgrades and technological advances were made in order to achieve optimum results and to reduce the associated complications. Various intragastric balloons have been approved for sale in Europe and South America. Vendors' growing concentration on technical developments, which is one of the key intragastric balloon industry trends, will also drive market growth. Different leading vendors concentrate on improving the capabilities and performance of intragastric balloon devices. The manufacturers also focus on balloon volume changes and longer implantation time.

Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Free Valuable Insights: Global Intragastric Balloon Market to reach a market size of $77.5 million by 2026

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.

Scope of the Intragastric Balloon Market Analysis

Market Segmentation:

By Administration

  • Endoscopy and
  • Pill Form

By Type

  • Single
  • Dual and
  • Triple

By Filling Material

  • Gas Filled and
  • Saline Filled

By End Use

  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Intragastric Balloon Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

FREQUENTLY ASKED QUESTIONS (FAQ):

The intragastric balloon market is projected to reach USD 77.5 million by 2026.

The major factors that are anticipated to drive the intragastric balloon industry include the increasing global prevalence of obesity, Growing preference of patients towards non-surgical treatment for addressing obesity, and rising demand for Triple Gastric Balloons Demand.

The Hospital segment captured the highest market share in 2019.

Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.


Purchase Report

 3600
 4320
 6048

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities